Serum 5-s-cysteinyldopa for identifying non-responders to nivolumab treatment of melanoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e21068
Abstract: e21068Background: Despite considerable advances in the treatment of metastatic melanoma, reliable markers to monitor treatment response are still lacking. 5-S-cysteinyldopa (5-S-CD) is a precursor ... read more here.
Keywords: melanoma; treatment; identifying non; serum cysteinyldopa ... See more keywords